N/A
Manufactured by Amerisourcebergen Drug Corporation
199 FDA adverse event reports analyzed
Last updated: 2026-04-15
COCOA BUTTER, PHENYLEPHRINE HCL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Amerisourcebergen Drug Corporation. The most commonly reported adverse reactions for COCOA BUTTER, PHENYLEPHRINE HCL include DYSPNOEA, FATIGUE, NAUSEA, CONSTIPATION, COUGH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for COCOA BUTTER, PHENYLEPHRINE HCL.
Out of 47 classified reports for COCOA BUTTER, PHENYLEPHRINE HCL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 199 FDA FAERS reports that mention COCOA BUTTER, PHENYLEPHRINE HCL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DYSPNOEA, FATIGUE, NAUSEA, CONSTIPATION, COUGH, DEATH. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Amerisourcebergen Drug Corporation in connection with COCOA BUTTER, PHENYLEPHRINE HCL. Always verify the specific product and NDC with your pharmacist.